https://olaparibinhibitor.com/....prevalence-and-also-
Disorder of p53 occurs regularly in human cancers. Therefore , p53 becomes one of the more encouraging objectives for anticancer treatment. A bacterial effector protein azurin triggers tumefaction suppression by stabilizing p53 and elevating its basal level. Nevertheless, the architectural and mechanistic foundation of azurin-mediated tumefaction suppression remains evasive. Here we report the atomic information on azurin-mediated p53 stabilization by combining X-ray crystallography with atomic
Like
Comment
Share
